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Five percent to 13% of all hypertension and 20% of resistant hypertension can be attributed to primary aldosteronism, 
of which unilateral aldosterone-producing adenoma (APA) is 
the most common curable cause.1,2 Early detection of APA is 
important because of significant increases in cardiovascular 
morbidity and mortality: congestive cardiac failure and isch-
emic heart disease are 2 to 5 times more prevalent,3 with an 
increase in 14-year mortality in these patients compared with 
matched patients with essential hypertension.4 Whether this 
additional risk is due directly to aldosterone excess, indepen-
dent of high blood pressure, or reflects greater average dura-
tion of hypertension before diagnosis, clinical outcome is 
considered to benefit from prompt recognition and removal 
of APAs.5
Over the past decade, new molecular stratifications have 
enabled the recognition of a group of smaller zona glomer-
ulosa (ZG)–like APAs.6–8 Compared with the classical large 
lipid-laden zona fasciculata (ZF)–like APA with mutations 
in inward rectifier potassium channel 4 (KCNJ5),6 not only 
is this ZG-like subtype of APA histologically and biochemi-
cally different, it also harbors hallmark somatic mutations 
in genes encoding a subunit of the voltage-gated calcium 
channel (CACNA1D),8 Na+/K+-ATPase (ATP1A1),8,9 Ca2+-
ATPase (ATP2B3),9 or the Wnt pathway mediator β-catenin 
(CTNNB1).10 Biochemically, these smaller ZG-like APAs have 
a higher capacity for aldosterone production; semiquantitative 
analysis of immunohistochemical staining has revealed that 
CYP11B2 score is inversely correlated with tumor size and 
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volume.11,12 In addition, ZG-like APAs are more responsive 
to angiotensin II, with higher levels of type 1 angiotensin II 
receptor mRNA.13,14 However, because of their small size, they 
are readily overlooked on cross-sectional imaging because 
computed tomography is unable to reliably detect adrenal 
tumors <5 to 6 mm.15 We hypothesized that specific gene prod-
ucts are responsible for the increased hormone production in 
these aldosterone-dense APAs and can potentially be used as a 
diagnostic biomarker when imaging proves inconclusive.
In seeking transcriptomic evidence to identify possible 
pathways of aldosterone production specific to the more 
compact, aldosterone synthase–dense APAs, we compared 
CACNA1D/ATP1A1-mutant with KCNJ5-mutant APAs.8 
Extracellular matrix (ECM) gene NPNT (nephronectin) was 
found to be the most upregulated, by 12-fold, in the former and 
confirmed a categorical difference between APA genotypes by 
immunohistochemistry. Discovered in the kidney in 2001,16 
NPNT was recently found to be a downstream Wnt target in 
the epidermis.17 This may be relevant in the adrenal, where 
normal adrenocortical development and steroidogenic activity 
of the ZG are dependent on the canonical Wnt pathway.18
Further examination of NPNT’s distribution presented in 
this article led us to hypothesize a key role in bringing ZG cells 
together to form functional units for aldosterone production 
through intercellular communication. This is supported by the 
observation, in rat ZG cells, of numerous tight junctions likely 
to be important in the establishment of electrical coupling,19 and 
the more recent discovery, only in intact adrenal slices, of oscil-
lating membrane potentials regulating aldosterone secretion.20
In this study, we have found that NPNT is directly involved 
in the physiological secretion of aldosterone in the adrenal. 
By using both cell lines and primary human adrenal cells, we 
have also uncovered a previously unknown role of NPNT in 
adhesion and cell survival.
Methods
Human Subjects
Human adrenal tissues from patients who underwent adrenalectomy 
after being diagnosed with unilateral APA or pheochromocytoma were 
obtained from Cambridge University Hospitals’ Human Research 
Tissue Bank postsurgery at Addenbrooke’s Hospital, Cambridge, 
United Kingdom. All tissues were obtained with approval from the 
Cambridgeshire Research Ethics Committee with written informed 
consent before surgery. Further details are provided in the online-only 
Data Supplement and clinical features in Table S1 in the online-only 
Data Supplement.
Cell Culture
Human adrenocortical carcinoma H295R cells were obtained from 
the American Type Culture Collection (ATCC CRL-2128), and 
grown in DMEM/Nutrient F-12 Ham supplemented with 10% FBS, 
100 U penicillin, 0.1 mg/mL streptomycin, 0.4 mmol/L l-glutamine, 
and insulin-transferrin-selenium at 37°C in 5% CO
2
. Human embry-
onic kidney cells were obtained from the American Type Culture 
Collection (ATCC CRL-1573) and grown in DMEM supplemented 
with 10% FBS.
Gene Overexpression and Silencing
Gene overexpression was performed using lipid-mediated cell trans-
fection lipofectamine 3000 (Thermo Fisher), whereas gene silenc-
ing was achieved using DharmaFECT 1 lipid transfection reagent 
(Dharmacon), both according to manufacturer’s instructions. Cells 
were harvested for analysis of mRNA and protein expression after 
48 hours. Further details are provided in the online-only Data 
Supplement.
RNA Extraction, Reverse Transcription, and 
Quantitative Real-Time Polymerase Chain Reaction
Fifty to 100 mg of tissue or 1×105 cells were used for each RNA 
extraction. Further details are provided in the online-only Data 
Supplement. Quantitative real-time polymerase chain reaction was 
performed using TaqMan ABI probes (Applied Biosystems) for NPNT 
(Hs01568126), ITGB1 (Hs00559595), and BCL2 (Hs00608023). 
CYP11B2 expression was quantified using custom-made TaqMan 
probes (Invitrogen) previously validated for specificity.21
Immunohistochemistry
Immunohistochemistry was performed using the peroxidase–antiper-
oxidase method on fresh frozen human tissue. In cases where fresh 
frozen tissue was unavailable, immunohistochemistry was performed 
on formalin-fixed, paraffin-embedded adrenal sections (4 μm) using 
an automated immunostainer with cover tile technology (Bond-III sys-
tem; Leica Biosystems). NPNT antibody (HPA003711, Sigma; 1:50 
dilution) and CYP11B2 antibody (custom mouse antihuman antibody 
from Dr Celso E. Gomez-Sanchez)22 were used as the primary antibod-
ies. Further details are provided in the online-only Data Supplement.
Aldosterone Measurement
Supernatant from cultured cells was used for aldosterone quantifica-
tion using the homogenous time resolved fluorescence assay (Cisbio 
assays) based on the fluorescence resonance energy transfer technol-
ogy, according to manufacturer’s instructions. The final fluorescence 
readout was conducted using a Pherastar FS microplate reader (BMG 
Labtech). Aldosterone concentrations were then normalized to total 
cell protein, quantified by the bicinchoninic acid protein assay (Pierce 
Biotechnology).
Firefly/Renilla Luciferase Assay
To measure the activity of Wnt transcriptional complex T-cell factor/
lymphoid enhancer factor (TCF/LEF), firefly luciferase and renilla 
luciferase activities were measured 48 hours after cotransfection with 
the Dual-Glo Luciferase Assay System (Promega) and normalized to 
the empty pCMV6 vector as described in the manufacturer’s protocol. 
Canonical Wnt signaling was quantified using the Cignal TCF/LEF 
reporter (luc) kit (SABiosciences).
Cell Confluency and Cytotoxicity Assay
To measure changes in H295R cell confluency post-NPNT silencing, 
time-lapsed images were obtained using an Incucyte system (Essen 
BioScience). To differentiate changes in cell proliferation from cyto-
toxicity, cell-impermeant cyanine dimer nucleic acid stain YOYO-1 
(Y3601; Life Technologies) was used. Further details are provided in 
the online-only Data Supplement.
Annexin V–Propidium Iodide Dual Stain
To assess apoptosis over time, cells were double labeled with annexin 
V-APC (550474; BD Pharmingen) and propidium iodide (Sigma). 
After silencing, adherent cells were trypsinized, added to any 
detached cells in the supernatant as previously described,23 stained 
with annexin V–propidium iodide, and analyzed with the FACSCanto 
II flow cytometer (Becton-Dickinson). Further details are provided in 
the online-only Data Supplement.
Xcelligence Cell Impedance Measurement and 
Hoechst Stain Assay
To evaluate changes in adhesion in response to NPNT, wells of 
an E-Plate 16 (ACEA Biosciences) were precoated with PBS, or 
10 μg/mL of BSA, NPNT, or laminin for 1 hour at 37°C as previ-
ously described.24 Cell adhesion was also measured by Hoechst 
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dye quantification of cells remaining on precoated wells post-wash. 
Further details are provided in the online-only Data Supplement.
Proteins and Chemicals
Proteins used in this study were BSA (A9576; Sigma), NPNT (4298-
NP-050; R&D systems), fibronectin (FC010; Millipore), and laminin 
(AG56P; Millipore). The selective porcupine inhibitor, LGK-974 (1 
μmol/L; Selleck Chemicals), as used previously,25 was used to ana-
lyze the effect of blocking all Wnt secretion.
Statistical Analysis
Results are expressed as mean values with SEM and compared using 
the 2-sided Student t test or by 1-way ANOVA followed by Tukey 
post hoc test. Significance level of P<0.05 was considered to indi-
cate statistical significance. Statistical analysis was performed using 
Graphpad Prism (Graphpad Software).
Results
NPNT Is Selectively Expressed in the Subtype of 
Smaller ZG-Like APAs and Able to Distinguish 
Between the 2 APA Classes
Microarray analysis revealed NPNT to be 12.2-fold upregu-
lated in the smaller ZG-like APAs with higher aldosterone 
synthetic capacity (Figure 1A). Validation with quantitative 
real-time polymerase chain reaction revealed a 9-fold dif-
ference; both ZG-like APAs and adrenocortical carcinomas 
(ACCs) had significantly elevated levels of NPNT compared 
with the ZF-like APAs (Figure 1B). The 2 APAs with the high-
est levels of NPNT harbored gain-of-function mutations in the 
Wnt gene CTNNB1.
In a further microarray comparing the ZG and ZF of 20 
human adrenals isolated via laser capture microdissection,26 
NPNT was on average 2-fold more highly expressed in the 
outer, aldosterone-producing zone of the ZG (Figure 1C). 
This selective expression was evident in protein immunohis-
tochemistry, in which NPNT staining is localized exclusively 
to the ZG (Figure 1D; Figure S1). When mounted on the 
same slide, NPNT also makes it easy to differentiate between 
the 2 APA subtypes as there is negligible staining in ZF-like 
APAs (Figure 1E; Figure S2). In all cases, NPNT expression 
appeared extracellular and strikingly periglomerular, sur-
rounding clusters of cells.
NPNT Expression Corresponds to Aldosterone 
Synthase CYP11B2 Expression
Although the ZG is the zone of physiological aldosterone pro-
duction, CYP11B2 staining is patchy.22 The overall analysis 
of 20 normal adrenal and APA samples revealed a significant 
positive correlation between NPNT and CYP11B2 encoding 
aldosterone synthase (r=0.82; P<0.0001; Figure 2A). At the 
protein level, areas of CYP11B2 expression also corresponded 
consistently with NPNT staining (Figure 2B; Figure S3). We 
also compared the ZG expression of genes in adrenal adjacent 
to a pheochromocytoma versus that next to an APA (ie, in a 
state of aldosterone excess). NPNT was 3.6-fold upregulated 
in ZG, compared with ZF, when adjacent to a pheochromo-
cytoma, but diminished or absent when adjacent to an APA 
(Figure 2C). The same observations were made at the protein 
level (Figure 2D). Similarly, CYP11B2 was 2-fold upregulated 
Figure 1. NPNT (nephronectin) is selectively expressed in normal adrenal zona glomerulosa (ZG), ZG-like aldosterone-producing 
adenomas (APAs), and adrenocortical carcinomas (ACCs). A, Microarray analysis of NPNT, comparing 8 zona fasciculata (ZF)-like 
adenomas with 5 ZG-like adenomas. B, Quantitative real-time polymerase chain reaction of NPNT, on mRNA extracted from 11 ZF-
like APAs and 10 ZG-like APAs differentiated based on their genotypic mutations, as well as 6 ACCs. C, Microarray analysis of NPNT, 
comparing 20 paired ZF and ZG (each pair from the same patient), isolated via laser capture microdissection. D, Representative 
immunohistochemistry of NPNT showing selective extracellular localization in the ZG of adrenal adjacent to a pheochromocytoma (4× 
magnification; inset: 20× magnification). E, Representative immunohistochemistry of NPNT comparing staining between ZF-like APA 
and ZG-like APA mounted on the same slide (4× magnification). In (A)–(C), bars represent mean expression per group±SEM. Statistical 
analyses were conducted by Student t test (A and C) or 1-way ANOVA followed by Tukey post hoc test (B). *P<0.05; **P<0.005; 
***P<0.0005. M indicates medulla; and NS, not significant.
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in ZG next to a pheochromocytoma versus next to an APA and 
7.8-fold higher on quantitative real-time polymerase chain 
reaction.
NPNT Drives Aldosterone Production
NPNT overexpression in H295R cells increased aldosterone 
synthesis compared with control (Figure 3A). Similarly, silenc-
ing NPNT by >75% reduced hormone production (Figure 3B). 
NPNT has been previously found to bind strongly and spe-
cifically to integrin receptor α8β1,16 with ≈100-fold higher 
affinity compared with other RGD motif-containing proteins 
such as fibronectin or vitronectin.27 In our study, silencing 
of ITGB1, encoding integrin subunit β1, by ≈80%, caused a 
similar reduction in aldosterone production comparable to 
silencing of NPNT (Figure 3C). This receptor silencing was 
accompanied by a 3.8-fold increase in NPNT mRNA expres-
sion (P=0.01).
NPNT Is a Wnt Target Gene and Produces 
Aldosterone via This Pathway
NPNT was found to be a Wnt/β-catenin target gene in skin, 
being induced by Wnt activation in the bulge and hair germ 
cells.17 We investigated the influence of Wnt on NPNT 
mRNA expression in H295R cells, using plasmids modulat-
ing Wnt signaling. To activate the Wnt canonical pathway, 
ΔN47 β-catenin, a strong constitutive inducer encoding an 
N-terminally truncated form of β-catenin resistant to prote-
olysis,28 was expressed. This led to a near doubling of NPNT 
expression levels. Conversely, to inhibit β-catenin–dependent 
gene transcription, we expressed ΔN-TCF4, a Wnt constitu-
tive repressor, because of an N-terminally truncated, domi-
nant-negative TCF4 protein lacking the β-catenin interaction 
domain.29 Wnt repression caused NPNT mRNA levels to halve 
(Figure 4A). To investigate the potential for negative feedback 
of NPNT on its own release, TCF/LEF activity was measured 
after changes in NPNT expression. Overexpressing NPNT 
caused a reduction in Wnt transcriptional activity, whereas 
silencing NPNT had the opposite effect (Figure 4B).
In cases where NPNT protein was added to the cell 
medium, on addition of Wnt inhibitor LGK-974, which blocks 
Wnt pathways upstream by binding the Wnt chaperone, por-
cupine, aldosterone production was nearly diminished by half 
compared with the controls (Figure 4C).
NPNT Is Proadhesive in Normal Adrenal and APA 
Cells
NPNT promotes cell adhesion in kidney mesangial cells30 and 
cardiomyocytes.31 Cell impedance was recorded as a measure 
of cell adhesion in wells coated with PBS, negative control 
BSA, NPNT, or positive control laminin. NPNT was proadhe-
sive in human embryonic kidney cells, normal primary adre-
nal cells, and cells cultured from ZF-like and ZG-like APAs 
Figure 2. NPNT (nephronectin) expression corresponds to CYP11B2 expression, with presence of negative feedback. A, Strong positive 
linear correlation between NPNT and CYP11B2 expression in 10 pairs of adenomas and their adjacent adrenal, r(18)=0.8273; P<0.0001. 
Inset: correlation plot excluding the 2 samples with highest NPNT expression, r(16)=0.6806; P=0.0019. Statistical analysis was conducted 
by Pearson product-moment correlation. B, Representative immunohistochemistry of NPNT and CYP11B2 in corresponding zona 
glomerulosa (ZG) areas in serial sections of the same adrenal tissue (20× magnification). C, Microarray expression of NPNT in 7 paired 
ZG and zona fasciculata (ZF) samples adjacent to a pheochromocytoma and 13 pairs next to an aldosterone-producing adenoma (APA). 
Bars represent mean expression per group±SEM. Statistical analysis was conducted by 1-way ANOVA followed by Tukey post hoc test. 
*P<0.05; **P<0.005; ***P<0.0005; NS, not significant. D, Negative feedback shown by representative immunohistochemistry of NPNT, in 
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(Figure 5Ai through Aiv). These findings are consistent with 
the hypothesized physiological role of NPNT in adrenal cell 
clustering for aldosterone production.
Intriguingly, NPNT had the opposite effect on H295R cells, 
with cell index reaching <50% of that in BSA-coated wells 
even after 4 hours (Figure 5Av). This suggested that NPNT 
was antiadhesive toward H295R cells, with cells tending to 
repel from the well surface. To reaffirm this finding, Hoechst 
stain assays were performed independently, with increasing 
concentrations of matrix coating on wells. Post-wash, there 
was a concentration-dependent increase in number of cells 
remaining (as measured by fluorescence) in positive control 
laminin–coated wells. However, in NPNT-coated wells, the 
number of remaining cells showed no significant difference 
from that in BSA-coated wells at every protein concentration, 
indicating only background levels of adhesion (Figure 5B).
NPNT Protects H295R Cells From Apoptosis
Cell confluency was 41% in the nontargeting controls com-
pared with 26% in the NPNT-silenced samples at 48 hours, 
as observed using kinetic live-cell imaging (Figure 6A). 
Kinetic measurement of cytotoxicity via the YOYO-1-iodide 
reagent revealed >3-fold increase in fluorescent (dead) cells 
when NPNT was silenced (Figure 6B). Annexin V–propidium 
iodide dual assay was used to monitor H295R cell staining 
over time. NPNT-silenced cells exhibited greater apoptosis 
over time, whereas samples with nontargeting siRNA consis-
tently showed basal levels of apoptosis (Figure 6C).
A prosurvival factor in the intrinsic apoptotic pathway,32 
transcription of BCL2 (B-cell lymphoma 2) was greatly sup-
pressed (>56%) in NPNT-silenced (siNPNT) cells (Figure 6D).
Discussion
The ZG of human adrenal is unusual among endocrine organs 
in that few cells produce its signature hormone, aldosterone, 
and yet there is a high incidence of APA occurrence, which is 
a common curable cause of hypertension. The ZG has likely 
evolved primarily to protect mammals from the scarcity of 
salt that has been the prevailing natural state, including for 
most of human history. It clearly also has the ability to adapt 
to chronic salt excess, to which the sparsity of aldosterone 
synthase is usually attributed,25 but perhaps imperfectly, and 
hence the frequent somatic mutations permitted by high rates 
of ZG cell migration and renewal. Our discovery of NPNT, 
and its putative roles, in the adrenal may help to explain the 
link between physiology and pathology.
We first discovered NPNT in the adrenal as the most upreg-
ulated gene in the smaller ZG-like APAs with higher aldoste-
rone synthetic capacity, harboring mutations of CACNA1D or 
ATP1A1, when compared with those with a ZF-like pheno-
type and mutations of KCNJ5. We also noted the exquisite 
ZG selectivity of its distribution in normal adrenal cortex.8 
These original findings have been reproduced by Åkerström 
et al.33 Interest in finding a mechanistic link between NPNT 
expression and blood pressure control has also been raised by 
a large-scale genome-wide association study in which a com-
mon single-nucleotide polymorphism in NPNT was associ-
ated with blood pressure regulation.34
The investigations that we now report show that NPNT 
is not just a marker of ZG cells but plays an essential role in 
normal adrenal physiology as a periglomerular ECM protein. 
Coupled with its steroidogenic and proadhesive properties, 
Figure 3. NPNT (nephronectin) drives aldosterone production, likely through receptor ITGB1. A, NPNT overexpression increases protein-
normalized aldosterone production, compared with vector control (n=4). B, NPNT silencing decreases protein-normalized aldosterone 
production, compared with nontargeting control (n=4). C, ITGB1 silencing decreases protein-normalized aldosterone production, 
compared with nontargeting control (n=4). Bars represent mean expression per group±SEM. Statistical analyses were conducted by 
Student t test. *P<0.05; **P<0.005; ***P<0.0005.
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this is consistent with a physiological role in adrenal cell 
clustering to form functional aldosterone-producing units in 
the ZG. Our work provides evidence that a matrix protein 
can play a role in driving hormone synthesis and, together 
with the regulation of ZG cell behavior, helps us understand 
why the ZG may be structured as it is and why tumors that 
resemble ZG are able to have a higher density of aldosterone 
production.
The ZG-selective staining suggests that the ECM of which 
NPNT is a major constituent supports zone-specific cellular 
behavior. In 2012, Hu et al20 made the crucial observation 
that isolated mouse ZG cells are too hyperpolarized to per-
mit calcium entry; however, ZG cells in an intact adrenal slice 
generate spontaneous membrane oscillations sufficient for 
recurrent Ca2+ signals, whose periodicity could sustain aldo-
sterone production. Therefore, these findings suggest that the 
aldosterone-producing ability of adrenal cells requires them 
to coexist in whole glomeruli, and this process could be regu-
lated by NPNT.
Although the ZG is the zone of physiological aldosterone 
production, this is not performed by all cells in the area, as 
evidenced by previous reports of patchy CYP11B2 staining.22 
But, the mechanism underlying why some ZG cells express 
CYP11B2, whereas others do not, is yet to be determined. 
Together with the consistent correlation between NPNT and 
CYP11B2 staining, and evidence showing NPNT increases 
aldosterone production, we propose that the role of this matrix 
protein is to cluster ZG cells together to form a functional unit 
as indicated by its periglomerular staining. This is supported 
by the recent proposal that Ca2+ and Ca2+-activated K+ chan-
nels in ZG cells, when grouped in rosette structures, act as 
a pacemaker generating the oscillations that regulate aldoste-
rone production.35 On NPNT silencing, although the cell-cor-
rected fall in aldosterone appears relatively small (Figure 3B), 
the absolute change consequent on reduction in both secretion 
and cell number is more substantial and likely to have consid-
erable impact in intact ZG.
In addition, our own finding of NPNT as an exquisitely 
selective ZG protein, 3.6-fold upregulated in ZG compared 
with ZF when adjacent to a pheochromocytoma, but dimin-
ished or absent when adjacent to an APA, suggests the 
disappearance of NPNT when physiological aldosterone 
secretion is not required. Analogous negative feedback has 
been reported in ZG adjacent to APA, where both subtypes 
of 3β-hydroxysteroid dehydrogenase-isomerase (3β-HSD), 
responsible for synthesizing progesterone from pregnenolone, 
were found to be suppressed.36
Our results also showed that NPNT promotes adhesion in 
normal adrenal cells and in both subtypes of APAs. This is 
consistent with previous reports of NPNT expression in hepa-
titis, inducing the development of granuloma-like cell clusters 
of hepatocytes.37 Cardiomyocytes grown on NPNT not only 
exhibited increased adhesion but also expressed high amounts 
of connexin-43 along their intercellular junctions, indicating 
Figure 4. NPNT (nephronectin) is a Wnt target gene and produces aldosterone via Wnt. A, Constitutive Wnt activation (ΔN-Bcat) induces 
NPNT mRNA expression, whereas constitutive Wnt repression (ΔN-TCF4) decreased NPNT expression compared with vector control 
(n=3). B, Wnt transcriptional complex T-cell factor/lymphoid enhancer factor (TCF/LEF) activity decreased in NPNT-overexpressed and 
increased in NPNT-silenced samples, as measured by firefly/renilla luciferase assay (n=6; n=4). C, Wnt inhibitor LGK-974 attenuated 
the increase in protein-normalized aldosterone production with addition of NPNT protein, compared with negative controls BSA and 
fibronectin (n=3). Bars represent mean expression per group±SEM. Statistical analyses were conducted by Student t test. *P<0.05; 
**P<0.005; ***P<0.0005.
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well-established intercellular communication, and couple 
electrically with each other resulting in synchronous beating.31
The link between increased cell adhesion and aldosterone 
production lies within the Wnt signaling system. Intracellular 
Wnt signaling diversifies into several major pathways, includ-
ing (1) the β-catenin/TCF–LEF pathway (canonical Wnt), 
which activates nuclear target genes; (2) the planar cell polar-
ity pathway; and (3) the Wnt/Ca2+ pathway, with the last 2 
being classified as the noncanonical Wnt pathways.38 Although 
NPNT expression is itself under control of the canonical path-
way, the noncanonical Wnt/planar cell polarity pathway is 
likely to be involved in mediating NPNT’s control of cell–cell 
adhesion and the localized assembly of ECM (Figure 4C).39 
It has been shown that an aberrant planar cell polarity path-
way leads to disruption of integrin β1–mediated interactions 
and, in turn, disorganization of the ECM.40 In addition, in 
line with the proposed role of NPNT, integrin β1 expression 
was reported to be crucial for adhesion of endothelial cells, 
with its absence causing focal adhesions to become short and 
disorganized.41
Although our experiments concentrated on the physi-
ological roles of NPNT in normal adrenal and benign APAs, 
its antiadhesive and antiapoptotic effect on H295R cells have 
drawn our attention to a potential role in malignancy. ACCs, 
although rare, are much more devastating than APAs. NPNT 
has been shown to confer apoptosis resistance in H295R cells 
by modulating the expression of prosurvival protein BCL2, 
whose role is to block caspase activation.32 This detachment 
of cells from the ECM often results in apoptotic cell death 
known as anoikis.42 Excess secretion of ECM components 
suppresses the physiological induction of anoikis in maintain-
ing normal tissue architecture43 and could explain the high 
levels of NPNT expression in adrenocortical carcinoma and 
immortalized H295R cells (Figure 1B).
However, benign APAs are much commoner than ACCs, 
and the main translational potential of NPNT may lie in its use 
as a diagnostic marker in patients with subcentimeter APAs, 
whose computed tomographic scan and adrenal vein sampling 
results are inconclusive. Recent publications have reported 
only 50% concordance between adrenal vein sampling and 
computed tomography, with >10% of patients aged >50 years 
lateralizing to opposite sides.44,45 Therefore, in vivo measure-
ment of adrenal NPNT could be a more accurate predictor of 
APA presence and even genotype, as the secreted protein may 
be measurable in adrenal vein samples routinely collected for 
unilateral APA diagnoses.
A limitation of the work to date is that the H295R cell line 
is not a perfect model for native ZG cells or ZG-like APAs, 
even though H295R cells have proven invaluable in study-
ing mechanisms involved in the physiological regulation of 
aldosterone production.46 Therefore, in the adhesion stud-
ies, primary adrenal cell types were also used. In addition, 
the H295R cell line is already known to harbor a CTNNB1 
mutation47 with high levels of NPNT; so, whenever applica-
ble, silencing NPNT was prioritized. Furthermore, our work 
on malignant cells in this study has been performed only on 
Figure 5. NPNT (nephronectin) is proadhesive in normal adrenal and aldosterone-producing adenoma (APA) cells, but antiadhesive in 
H295R. A, NPNT is proadhesive in (i) HEK, (ii) normal primary adrenal, (iii) zona fasciculata (ZF)–like APA, and (iv) zona glomerulosa 
(ZG)–like APA, but antiadhesive in (v) H295R, as demonstrated by wells precoated with PBS, BSA, NPNT, or laminin, and measured by 
Xcelligence cell impedance as cell index over time (4 h for cell lines, 10 h for primary adrenal cells; n=2 for ZF-like APA and ZG-like APA, 
n=4 for the rest). B, NPNT is antiadhesive in H295R cells, as confirmed by Hoechst fluorescent stain assay measuring % maximum 
fluorescence as a representation of number of cells adhered to well with increasing concentrations of BSA, NPNT, and laminin precoating 
(n=3 for each protein at each concentration). Bars represent mean values per group±SEM.
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H295R, because of the lack of other human adrenal carcinoma 
cell lines amenable to transfection. A further limitation is that 
centripetal migration of adrenocortical cells cannot be studied 
in human adrenal. Because of the dispersed-cell nature of the 
experiments which we can currently undertake, the effects of 
NPNT’s various roles in the adrenal may be underestimated 
in this study. The full impact of NPNT will become apparent 
during experiments on intact adrenal with preserved cell–cell 
contacts. Future work may involve a ZG-selective conditional-
knockout of NPNT, by crossing a floxed-NPNT mouse48 with 
an aldosterone synthase-Cre recombinase mouse.49
In conclusion, we have discovered NPNT to be an exqui-
sitely ZG-selective ECM protein in the adrenal. The distri-
bution of NPNT defines the glomeruli anatomically, and its 
actions explain the critical role of glomerular structure in reg-
ulation of aldosterone production and hence blood pressure 
control. The high levels of NPNT in the smaller aldosterone-
dense ZG-like APA subtype, as well as in ACCs, suggest future 
potential as a diagnostic marker or target for novel therapies.
Perspectives
Primary aldosteronism is the most common secondary cause 
of hypertension, of which APAs make up 30% to 50% of cases, 
with hypertension potentially curable by adrenalectomy. 
Recently, the discovery of somatic mutations in CACNA1D/
ATP1A1/ATP2B3/CTNNB1 characterize a subtype of small 
ZG-like APAs that are also histologically and biochemically 
distinct from the classical large KCNJ5-mutant ZF-like APAs. 
Investigations into transcriptomic differences between the 2 
subtypes revealed NPNT, encoding the matrix protein neph-
ronectin, to be the most upregulated gene in ZG-like versus 
ZF-like APAs. Subsequent investigations have shown NPNT 
not only to be just a biomarker of ZG-type APAs but also to 
play an important role in normal ZG. Found to be under canon-
ical Wnt control, the distribution and effects of NPNT suggest 
that it defines the anatomy and function of normal adrenal 
glomeruli, driving steroidogenesis and adhesion physiologi-
cally. In contrast, in immortalized adrenocortical carcinoma 
cells, NPNT exerts antiadhesive and antiapoptotic effects. 
Clinical measurement of NPNT in adrenal vein blood may 
have application in diagnosis of unilateral APAs. Complete 
cure of hypertension, on removal of CTNNB1-mutant APAs, 
may be predicted through unilateral detection of secreted 
proteins such as NPNT during adrenal vein sampling. Apart 
from its potential as a diagnostic marker, the high levels of 
NPNT in the smaller aldosterone-dense ZG-like APA subtype, 
and in ACCs, make it an attractive molecular target for novel 
therapies.
Figure 6. NPNT (nephronectin) protects H295R cells from apoptosis. A, NPNT silencing causes cell confluency to remain low over  
72 h, as measured by kinetic live-cell imaging in groups that are untreated or treated with nontargeting siRNA (n=3; P<0.0001 between 
siNPNT and nontargeting). B, NPNT silencing drives active cell death, as shown by kinetic measurement of cytotoxicity using YOYO-
1 iodide reagent, comparing number of fluorescent (dead) cells in groups that are untreated, treated with positive control puromycin, 
nontargeting siRNA, or specific siRNA against NPNT (n=4; P<0.0001 between siNPNT and nontargeting). C, NPNT silencing causes cell 
death via apoptosis, as shown by flow cytometric analysis using annexin V-APC and propidium iodide double staining in groups that 
are treated with nontargeting siRNA or specific siRNA against NPNT. Quadrant analysis of the gated cells in FL-1 versus FL-2 channels 
was from 10 000 events. Annexin V+/PI− (lower right quadrant) areas stand for early apoptotic cells, and Annexin V+/PI+ (upper right 
quadrant) areas stand for late apoptotic or necrotic cells. Graph below shows percentage of total apoptotic cells at 12, 24, 36, and 48 h 
post-silencing. D, NPNT silencing causes apoptosis through reduction of BCL2, a prosurvival factor in the intrinsic apoptotic pathway, 
as shown by mRNA expression in groups that are treated with nontargeting siRNA or specific siRNA against NPNT (n=6). Bars represent 
mean expression per group±SEM. Statistical analyses were conducted by Student t test. *P<0.05; **P<0.005; ***P<0.0005.
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What Is New?
•	NPNT (nephronectin), selectively expressed in the zona glomerulosa of 
human adrenal cortex and of aldosterone-producing adenomas arising 
from this, is shown to have roles in steroidogenesis, cell adhesion, and 
protection of adrenocortical cells from apoptosis.
What Is Relevant?
•	Aldosterone-producing adenomas are greatly underdiagnosed, one rea-
son being the small size of those appearing to arise in the zona glomeru-
losa of adrenal cortex. Recognition of their separate identity and of the 
role of NPNT in steroidogenesis will encourage clinicians to give greater 
consideration to small adenomas.
Summary
NPNT is an exquisitely selective, Wnt-driven zona glomerulosa pro-
tein, which seems to play an important role in steroidogenesis, by 
promoting adhesion of ZG cells and preventing apoptosis.
Novelty and Significance
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MATERIALS AND METHODS 
 
Human subjects 
Post-surgery, APAs and their paired adjacent normal adrenal were identified and 
macroscopically dissected by histopathologists and separated into three categories 
for processing: a) snap-frozen in liquid nitrogen and then stored at -70°C for 
immunohistochemistry or DNA extraction, or b) stored in RNA-later for RNA 
extraction or c) digested with collagenase for two hours and then placed in 
Dulbecco's Modified Eagle's Medium (DMEM) /Nutrient F-12 Ham supplemented 
with 10% fetal bovine serum (FBS), 100 U penicillin, 0.1 mg/ml streptomycin, 0.4 mM 
L-glutamine and insulin–transferrin–sodium selenite (ITS) media at 37 °C in 5% CO2 
for cell culture. 
 
The Cambridge database provided 8 ZF-like APAs and 5 ZG-like APAs for 
microarray analysis between the two tumor subtypes. A further 3 ZF-like APAs and 5 
ZG-like APAs were used for subsequent qRT-PCR validation of microarray findings. 
 
Gene overexpression and silencing  
For NPNT overexpression, H295R cells were transfected with GFP-tagged NPNT 
(RG230311, OriGene) or vector control pCMV6-AC-GFP plasmids. For Wnt 
constitutive activation, H295R cells were transfected with pcDNA ∆N47 β-catenin, a 
gift from Eric Fearon (Addgene plasmid #19287); for Wnt constitutive repression, 
transfection was with pcDNA ∆N TCF4, a gift from Bert Vogelstein (Addgene plasmid 
#16513), or vector control pcDNA3.1 (Invitrogen).  
 
Gene silencing was achieved using short interfering RNA (siRNA) in the form of ON-
TARGETplus human NPNT/ITGB1 or ON-TARGETplus Non-Targeting siRNA as 
negative control. Short interfering RNA (siRNA) sequences were as follows: NPNT 
5′-GCAAAUUAUGAGAGUGAGU-3′, Non-targeting 5′-
UGGUUUACAUGUCGACUAA-3′. Transient silencing of ITGB1 was achieved using 
a pool of four siRNA duplexes that each target a sequence of the ITGB1 transcripts 
(ONTARGETplus SMARTpool, Dharmacon). A mixture of four non-targeting siRNA 
duplexes was used as a negative control (ON-TARGETplus Non-targeting Pool, 
Dharmacon). The final concentrations of DharmaFECT 1 and the siRNA in each 
transfection were 0.2% (v/v) and 25nM respectively, in antibiotic-free complete 
medium. Efficiency of knockdown was evaluated by qRT-PCR 48h post-transfection.  
 
RNA extraction, reverse transcription and quantitative real-time PCR 
RNA extraction from tissues was carried out by dissecting and homogenising 50-
100mg of tissue in a lysis matrix using a homogenizer with 1ml of TRIzol reagent 
(Life Technologies). To extract RNA from cells, 1x105 cells were stored in RNAlater 
(Ambion) until 500μL TRizol was added. Total DNA-free RNA was isolated using the 
PureLink® RNA Mini Kit and the PureLink® DNase Set (Life Technologies) 
according to manufacturer’s instructions. On column DNase treatment was 
performed on all RNA samples to elute DNA-free RNA. Concentration of RNA was 
determined by Nanodrop spectrophotometry prior to reverse transcription. A two-step 
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reverse transcription reaction was performed using AMV reverse transcriptase from 
Reverse Transcription System (Promega) according to manufacturer’s instructions.  
 
Immunohistochemistry 
Immunohistochemistry was carried out using the unlabelled antibody enzyme 
(peroxidase-antiperoxidase [PAP]) method68 on fresh frozen human tissue. Sections 
of fresh frozen adrenals (14 μm) were thaw-mounted onto microscope slides pre-
treated with poly-L-lysine to aid adhesion of the tissue section, and stored at -70°C. 
When required, slides were air-dried overnight at room temperature and fixed by 
immersion in ice-cold acetone for 10 min. In cases where fresh frozen tissue was 
unavailable, immunohistochemistry was performed on formalin-fixed, paraffin-
embedded adrenal sections (4 μm) using an automated immunostainer with cover 
tile technology (Bond-III system, Leica Biosystems). Negative controls, in which the 
primary antibody was omitted, resulted in complete absence of staining. Images 
were captured using a standard bright-field microscope, a U-TV1-X digital camera 
and CellD software (Olympus UK).  
 
Cell confluency and cytotoxicity assay 
Time-lapsed images were obtained using an Incucyte system (Essen BioScience), 
with ×4 magnification from 16 spots within each well of a 24-well plate every 2h over 
72h. Cell confluency was automatically determined from bright-field images at 
different time-points, using the integrated Incucyte software. YOYO-1 was diluted in 
cell culture medium and used at a final concentration of 78nM for both experimental 
and control wells. YOYO-1 fluorescence was measured every 4 h for a period of 72 
h, and addition of YOYO-1 alone did not induce cytotoxicity. As YOYO-1 only 
fluorescently stains the nuclear DNA of cells that have lost plasma membrane 
integrity, cell death can be monitored in real-time with the Incucyte imaging system 
and fluorescent signal quantified using the Incucyte FLR object counting algorithm 
(v2.0), finally represented as the object count per mm2. Analysis parameters were as 
follows: Segmentation- Adaptive 2.0; Background intensity- 20.0 AU; Foreground 
intensity- 60.0 AU; Manual adjustment- 0.0 AU; Refinement- Edge split v2.0; Edge 
sensitivity- 0.00; Analysis filter- Area >=50µm2. 
 
Annexin V-propidium iodide dual stain 
Approximately 1 × 106 cells/mL were washed twice with cold PBS, centrifuged at 300 
x g, and subsequently re-suspended in 1x binding buffer. 100μL of the solution (1 × 
105 cells) was then transferred to a 5ml tube, before 5μL of Annexin V- APC and 5μl 
PI was added. Cells were vortexed gently and incubated for 15 min in the dark at 
room temperature, followed by addition of 400μL 1x binding buffer. Finally, samples 
were analysed by flow cytometry within 1 hour with a Becton-Dickinson FACSCanto 
II flow cytometer and all data was acquired with the FACSDiva Software. . 
Trypsinisation of adherent cells led to an overall higher basal apoptotic level across 
both groups treated with non-targeting siRNA and NPNT-specific siRNA. 
 
Xcelligence cell impedance measurement and Hoechst stain assay 
Cell adhesion was monitored continually every 15 min using the Xcelligence cell 
impedance system (RTCA DP Analyzer, Roche) placed in an incubator (humidified 
atmosphere 5% CO2 at 37 °C) for a period of 4 to 10 h depending on cell-type. Real-




Cell adhesion was also measured by Hoechst dye quantification of cells remaining 
on pre-coated wells post-wash. A 96-well clear-bottom black plate was pre-coated 
with 50μL of purified protein diluted in PBS to varying concentrations and incubated 
overnight at 37 °C. This solution was then aspirated and non-specific binding blocked 
with 50μL of 1% BSA in PBS, for 1h at 37 °C. Once again, the solution was aspirated 
and the wells washed twice with 0.1% BSA in PBS. After trypsinization and in pellet 
form, cells were washed and centrifuged 3x in serum-free DMEM⁄ F-12 medium. 
100μL of the cell suspension (4x104 cells) was transferred into each well and 
incubated for 2h at 37 °C with 5% CO2. The plate was then agitated on a shaker at a 
fixed rate for 5s at 1000rpm, and non-adherent cells removed by gentle aspiration.  
 
Following that, cells adherent to wells were fixed with 4% formaldehyde for 20 min 
followed by washing 5x with PBS. These cells were then stained with Hoechst 33342 
(5 µg/ml in 0.001% Triton X-100) for 90min at room temperature. After washing with 
PBS twice more, each well was filled with 100μl of PBS and fluorescence intensities 
measured using a microplate reader (Synergy HT, Biotek), with an excitation 






















































































Figure S2. NPNT immunohistochemistry in ZF-like APA vs ZG-like APA 
mounted on the same slide, differentiating between the two APA subtypes with 








Figure S3. NPNT expression in aldosterone-producing cell clusters (APCCs) 
correspond consistently with CYP11B2 expression, as demonstrated by 
staining of serial sections.  
(20x magnification) 
 
 
 
